You must log in to view this page.

Virax Biolabs Group Limited

NASDAQ: VRAX
Share price (12/20/24): $1.75
Market cap (12/20/24): $7.595 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 03/31/24 FY 2024

Late filing notification for annual report of foreign issuer

ended 03/31/23 FY 2023

ended 03/31/22 FY 2022

Late filing notification for annual report of foreign issuer

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Prospectus supplement

Prospectus supplement

Ownership Filter

Armistice Capital, LLC

Armistice Capital, LLC

News Filter

Biolabs' CEO James Foster Issues Letter to Shareholders

Announces Agreement With Tebubio to Expand Distribution of ImmuneSelect Across the European Union, Norway, and Switzerland

Unaudited Condensed Consolidated Interim Financial Statements as of September 30, 2024

Notice of 2024 Annual General Meeting of Shareholders to Be Held on December 12, 2024, at 2:00 p.m., Local Time

Announces Distribution Agreement With Europa Biosite to Commercialize ImmuneSelect in the United Kingdom and Ireland

Proxies

No filings in this category.

Other Filter

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness

Correspondence with the SEC